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Objective: to identify the epidemiological profile of hypertension patients, how much they 
understand about the disease and the rate of adherence to treatment by these patients who 
had been hospitalized in the Brazilian emergency service. Methods: this cross-sectional study 
was performed with 116 patients, both male and female and aged over 18 years, who had been 
hospitalized in the Emergency Service of a University Hospital between March and June, 2013. 
The studied variables were data referring to socio-demographics, comorbidities, physical activity 
and knowledge regarding the disease. Patient adherence to treatment and the identification 
of the barriers were respectively evaluated using the Morisky test and the Brief Medication 
Questionnaire. Results: most of the patients involved in this study were women (55%), with white 
skin color (55%), married (51%), retirees or pensioners (64%) and with a low educational level 
(58%). Adherence to treatment, in most cases (55%), was moderate and the most prevalent 
adherence barrier was recall (67%). When medication was acquired at no cost to the patient, 
there was greater adherence to treatment. Conclusion: this study’s patients had a moderate 
understanding about the disease. The high correlation between the number of drugs used and 
the recall barrier suggests that monotherapy is an option that can facilitate treatment adherence 
and reduce how often the patients forget to take their medication.
Descriptors: Hypertension; Therapeutics; Medication Adherence; Knowledge; Emergency Medical 
Services; Emergency Nursing.
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Introduction
Systemic Arterial Hypertension (SAH) is a public 
health problem that is characterized by a high prevalence 
and low treatment adherence rate, which is one of the 
major modifiable risk factors for Cardiovascular Diseases 
(CVDs). The main goal of treating SAH is to reduce 
cardiovascular morbidity and mortality(1).
According to the World Health Organization (WHO), 
17.3 million people died from CVDs in 2008, with 9.4 
million of these deaths being due to complications 
arising from SAH in the same period. In addition, it is 
estimated that more than 23 million people will die as a 
result of CVDs by 2030(2-3).
One of the most important factors for effectively 
controlling Blood Pressure (BP) is patient adherence to 
treatment, given that 40 to 60% of patients with SAH 
do not use medication for such(4). Studies have shown 
that non-adherence to medication treatment, which 
is associated with medicine costs and patient socio-
demographic conditions, is one of the main explaining 
factors for people demanding emergency services(5).
There are many factors that can explain such 
non-adherence to SAH treatment, which makes it a 
complex and multidetermined phenomenon(2). These 
patients often have lower incomes, have difficulties 
accessing services, consume greater quantities of 
alcohol and undertake irregular medical follow-ups(2,6). 
Thus, identifying non-adherence to antihypertensive 
treatment, as well as factors related to this condition, 
can make developing an intervention plan possible. 
The objective of this plan was to enhance adherence 
to treatment, reduce complications caused by SAH and 
decrease hospitalization numbers, which can reduce 
costs that have to be covered by the health system.
Therefore, this study’s objective was to identify 
the epidemiological profile, the existing understanding 
regarding the disease and the barriers for non-adherence 
to the treatment by patients with SAH, who had been 
hospitalized in the emergency room of a university 
hospital.
Methods
This cross-sectional study was performed from 
March 2013 to June of the same year in São Paulo 
Hospital’s Emergency Service. São Paulo Hospital is the 
university hospital for the Federal University of São Paulo 
(UNIFESP) and cares for approximately 1000 patients at 
its Emergency Service on a daily basis.
The study was approved by the Research Ethics 
Committee from UNIFESP, under CAEE protocol number 
13513713.0.0000.5505. Patients were permitted to be 
involved in this study after they had read and signed a 
Term of Free and Informed Consent (TFCC).
The non-probabilistic intentional sample was made 
up of 116 patients who had been hospitalized  for 
more than 24 hours in the Emergency Service. These 
patients had to have had some kind of clinical or surgical 
diagnosis and personal history of SAH and been in drug 
treatment for at least one month. The patients were 
both male and female, aged over 18 years and had no 
cognitive impairment.
The researcher collected data from these patients 
by means of a questionnaire. The researcher read all the 
questions from the questionnaire to each patient in one 
meeting, with the mean time taken per interview being 
25 minutes.
The variables studied were: age, gender, skin color, 
personal and family income, existence of associated 
diseases, physical activity level, weight, height, 
abdominal circumference, consumption of alcoholic 
beverages and understanding regarding the disease.
Any singular individual was classified as being 
physically active when he/she communicated 
undertaking aerobic physical activity such as: walking, 
running, cycling, dancing, swimming, at a 3 to 5 times a 
week frequency, with a 30-minute minimum duration(1).
Weight and height data were collected verbally from 
the patient, the abdominal circumference was measured 
using a tape measure at the umbilical line level.
Alcoholic beverage consumption was considered 
excessive when it exceeded 30 g alcohol/day(1).
Understanding regarding SAH was evaluated by 
means of the following questions: Do you think high 
blood pressure is a serious disease? In addition to 
medication, do you use any other types of treatment for 
high blood pressure?  Do you think high pressure results 
in complications to your health? Do you think there is a 
cure for high blood pressure? Which factors do you think 
may be related to high blood pressure?
The Morisky test was used in order to evaluate 
patient adherence to treatment, this test consisted 
of four questions: 1) Do you ever forget to take 
your medicine? 2) Are you careless at times about 
taking your medicine? 3) Do you sometimes stop 
taking your drugs when you feel better? 4) Do you 
sometimes stop taking your drugs if they make 
you feel worse? A patient is classified in the high 
adhesion group when he/she gives negative four 
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answers; in the medium adhesion group when he/
she gives one or two positive answers; and in the 
low adhesion group when he/she gives three or four 
positive answers(7).
In order to identify the barriers to treatment 
adherence, from the patients’ perspective, the 
Brief Medication Questionnaire was used. This 
questionnaire is divided into three headings: the first 
evaluates the patient’s behavior in relation to his/her 
adherence to a prescribed treatment regimen, the 
second assesses the patient’s beliefs regarding the 
effectiveness of the treatment and opinions related 
to unwanted adverse effects, and the third heading 
identifies problems in relation to remembering to 
take the medication (recall). The presence of an 
affirmative response in each of the headings identifies 
a barrier to the prescribed treatment regimen, beliefs 
in the treatment and/or memory taking his/her 
medication(8).
The data was descriptively analyzed for the 
following variables: age, gender, skin color, personal and 
family income, existence of associated diseases, physical 
activity level, weight, height, abdominal circumference, 
consumption of alcoholic beverages and understanding 
regarding the disease. Frequency and percentages 
were used for categorical variables. Number of valid 
observations (n), mean, median, Standard Deviation 
(SD), minimum and maximum values were presented 
for continuous numerical variables.
Analysis of variance (ANOVA) was used in order to 
compare the continuous variables with the adherence 
rate and with the barriers for non-adherence to the 
treatment by patients. The Chi-square test was used 
in order to compare the categorical variables with the 
adherence rate and with the barriers for non-adherence 
to the treatment by patients, and, when necessary, the 
Fisher’s exact test or the likelihood ratio test was used. 
The considered level of significance was p<0.05.
Results
The mean patient age was 61.5 years old, most of 
whom were women (55%), with white skin color (55%), 
married (47%) and retirees or pensioners (63%). With 
regards to education level, the majority (59%) had 
not completed primary education. The most common 
income level was between one and three Brazilian 
monthly minimum wages (76%).
The most frequently reported comorbidities by 
patients were: Dyslipidemia (40%) and diabetes mellitus 
(34%). The number of different classes of medications 
used by patients to treat SAH ranged from 1 to 5 drugs.
The sociodemographic characteristics and 
comorbidities of the patients included in this study can 
be seen in Table 1.
Table 1 - Distribution of hypertensive patients, 
according to their sociodemographic characteristics and 
comorbidities. São Paulo, SP, Brazil, 2013
Characteristics N*=116 (%)
Age (years)
Mean(sd†) 61.5 (14.8)
Gender
Male 52 (45)
Female 64 (55)
Skin color
White 64 (55)
Non white 52 (45)
Marital status
Married 55 (47)
Single 18 (16)
Widowed 24 (21)
Separated 15 (13)
Other 4 (3)
Occupation
Employed/self-employed 26 (23)
Unemployed 8 (7)
Work from home 8 (7)
Retired/pensioner 74 (63)
Education
No education 8 (7)
Incomplete primary school 68 (59)
Complete primary school 12 (10)
Incomplete high school 6 (5)
Complete high school 12 (10)
Incomplete higher 3 (3)
Complete higher 7 (6)
Family income (number of monthly 
minimum wages)‡
< 1 9 (8)
1 to 3 88 (76)
3 to 5 (14)
> 5 3 (2)
* Total number of patients
† Standard deviation
‡ Brazilian minimum monthly salary, in 2014: R$724,00
In regards to blood pressure levels found in the 
patients, the mean systolic blood pressure was 126.3 
(28.8 ±) mmHg and the mean diastolic blood pressure 
was 81.2 (± 19.3) mmHg. The mean heart rate was 
79.2 (± 17.7) bpm. The mean abdominal circumference 
was 97.3 (± 15.4) cm.
The most recognized SAH risk factors by patients 
were salt consumption (94%), being overweight (89%) 
and physical inactivity (88%).
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The rate of patient adherence to treatment and the 
barriers to this adherence can be seen in Table 2, as 
evaluated by the Morisky test and the Brief Medication 
Questionnaire, respectively.
The majority of patients (56%) presented a medium 
adherence to treatment, with the main barrier to this 
adherence being remembering to use the medication 
(recall), which was found in 67% of patients.
Table 3 shows the correlations between the 
sociodemographic and clinical variables of the patients 
and the variables from the Morisky test.
Upon analyzing the data regarding how the 
medication was acquired, patients for whom the 
drug was fully supplied without charge showed 
themselves to have a higher percentage of treatment 
adherence. Patients with dyslipidemia had a higher 
percentage of medium treatment adherence, while 
that for those without dyslipidemia had a higher 
percentage for low adherence.
Table 4 shows the correlations between 
sociodemographic and clinical variables of the patient 
and the understanding regarding the disease and the 
variables from the Brief Medication Questionnaire 
(BMQ).
When the regimen heading is compared with 
categorical variables, a higher percentage of treatment 
adherence in white patients can be identified, as is the 
case with those who believed that SAH is a serious disease.
In regards to the belief heading, patients with 
higher heart rates during the evaluation, patients who 
work from home, retirees/pensioners or the unemployed 
and physically inactive presented belief barriers 
regarding the effectiveness of the treatment and its 
adverse effects.
Table 2 - Rates of patient adherence to treatment and the types of barriers to this adherence, according to the 
Morisky test and the Brief Medication Questionnaire, respectively. São Paulo, SP, Brazil, 2013
Rate of adherence/types of barrier n (%)
Morisky test
High adherence 34 (30)
Medium adherence 65 (56)
Low adherence 17 (14)
Brief Medication Questionnaire
Regimen barrier 43 (37)
Belief barrier 26 (22)
Recall barrier 78 (67)
Table 3 - Correlation between the Morisky test and the sociodemographic and clinical variables. São Paulo, SP, Brazil, 2013
Sociodemographic and clinical variables
Morisky test
High adherence
N* (%)
Medium 
adherence
N (%)
Low adherence
N (%)
Total
N (100%) p-value
Medication acquisition
Fully supplied without charge 28 (38.4) 35 (47.9) 10 (13.7) 73 (62.9) 0.0409
Paid for in total 2 (14.3) 11 (78.6) 1 (7.1) 14 (12.1)
Partially paid for 4 (13.8) 19 (65.5) 6 (20.7) 29 (25)
Total of patients 34 (29.3) 65 (56) 17 (14.7) 116 (100)
Dyslipidemia
Yes 15 (31.9) 30 (63.8) 2 (4.3) 47 (40.5) 0.0322
No 19 (27.5) 35 (50.7) 15 (21.7) 69 (59.5)
Total of patients 34 (29.3) 65 (56) 17 (14.7) 116 (100)
* N=total number of patients
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Regarding the recall heading, patients who used a 
larger number of different drugs showed higher recall 
percentage barriers.
Discussion
In this study, most of the patients were female, 
had an mean age of 61.5 years and a low education 
level. These patients had an emergency service demand 
profile that was similar to other studies conducted 
with hypertensive patients in first aid units(4,9). SAH is 
more common in men aged up to 50 years(10), however, 
whenever more women are observed diagnosed with 
SAH, it can be explained by the fact that women are 
more likely to seek health services, with a view to 
discover the diagnosis of the disease(11).
Comorbidities diabetes mellitus and Dyslipidemia 
were present in 34 and 40% of the interviewees during 
this study, respectively. Besides SAH, the presence of 
other comorbidities in the patients involved in this study 
can be linked to bad eating habits and lack of physical 
activity, which may give rise to the appearance of many 
chronic illnesses, which are often asymptomatic. Medical 
treatment, when arranged alongside lifestyle change, is 
the best way of reducing and preventing the damage 
generated by these chronic diseases(1).
As regards the blood pressure levels found in this 
study, the mean systolic blood pressure was 126.3 
Table 4 - Correlation between the headings from of the Brief Questionnarie Medication and sociodemographic, clinical 
and understanding of the illness by the patient variables in this study. São Paulo, SP, Brazil, 2013
Demographic variable
BMQ* -  regimen heading
Adherence
N† (%)
Potential non-
adherence
N (%)
Total
N(100%) p-value
White Skin Color
Yes 46 (71.9) 18 (28.1) 64 (55.1) 0.0269
No 27 (51.9) 25 (48.1) 52 (44.8)
Total of patients 73 (62.9) 43 (37.1) 116 (100)
Do you think the disease is serious?
Yes 69 (67.0) 34 (33) 103 (88.8) 0.0152
No 4 (30.8) 9 (69.2) 13 (11.2)
Total of patients 73 (62.9) 43 (37.1) 116 (100)
Clinical variable
BMQ* - Belief heading
With barrier With no barrier Total p-value
Heart rate
Mean (sd‡) 77.3 (16.3) 85.0 (21.1) 79.2 (17.7) 0.0317
Median (minimum-maximum) 80.0 (44-130) 82.0 (60-140) 80.0 (44-130)
Total of patients 90 26 116
Employment status
Employed 14 (93.3) 1 (6.7) 15 0.0379
Unemployed 6 (75.0) 2 (25.0) 8
Self-employed 11 (100) - 11
Retired/pensioner 54 (73.0) 20 (27.5) 74
Work from home 05 (62.5) 3 (37.5) 8
Total of patients 90 (77.6) 26 (22.4) 116
Physical activity
Active 13 (100) - 13 0.0387
Inactive 77 (74.8) 26 (25.2) 103
Total of patients 90 (77.6) 26 (22.4) 116
Understanding regarding the disease
BMQ* - Recall heading
With barrier With no barrier Total p-value
How many medications?
Mean (sd) 1 (0) 2.06 (0.8) 1.75 <0.0001
Median (minimum-maximum) 1 (1-1) 2 (1-5) 1.5 (1-5)
Total of patients 38 78 116
* Brief Medication Questionnarie
† Total number of patients
‡ Standard deviation
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mmHg and the mean diastolic blood pressure was 81.2 
mmHg. These values were lower than those found in the 
literature. A similar study showed higher blood pressure 
levels, namely mean systolic blood pressure of 174 
mmHg and mean diastolic blood pressure of 109 mmHg. 
This particular study also revealed that the patients 
treated in the first aid unit reported using controlled salt 
intake as a measure to control SAH(9). Despite this similar 
study having reported this controlled salt intake, it did 
not describe how the patients controlled the amount of 
salt in their food(9). The fact that the mean blood pressure 
was lower in this similar study may be associated with 
the respondents having been hospitalized for over 24 
hours in the emergency service, where they would have 
received antihypertensive therapy and restricted sodium 
intake through the low-sodium diet provided, which, 
according to the WHO, is 5 g of salt per day or 2 g of 
sodium(1).
The Morisky test classified most of the interviewed 
patients as being in the medium adherence group 
(56%). The adherence rate found during this study is 
close to those found in the literature(12-13). The medium 
and low antihypertensive treatment adherence may be 
associated to age, to using more than one different drugs 
to control blood pressure, and to lack of supervision 
and control of the disease(12,14). In addition, measuring 
patient treatment adherence is challenging, since there 
has been no consensus reached, from among the 
methods used, regarding which is the best method that 
can be considered the gold-standard(15-16).
In regards to the barriers for non-adherence to 
treatment, 67% of the patients presented a significant 
(p<0.0001) barrier in the recall section of the BMQ 
when the patient was using more than one medication, 
of any class, to control his/her blood pressure. These 
data are in line with another study, which pointed out 
that the main reason for patients’ non-adherence was 
due to them forgetting to use their medication(17). 
These results indicate that the difficulty of patients 
remembering to take their medication is directly 
proportional to the number of drugs that they use. 
This suggests that monotherapy is a good strategy to 
encourage adherence to antihypertensive treatment(17). 
Another study, performed at the basic health network 
in the Southern Region of Brazil, pointed out that the 
complex pharmacotherapy involved in treating SAH is 
one of the factors associated with non-adherence to 
drug treatment, followed by the dissatisfaction with the 
health service(18).
The majority of interviewees (88%) reported that 
they understand that hypertension is a serious illness. 
There was an observed significant correlation (p = 
0.0152) between the understanding of the disease’s 
severity and a higher percentage of adherence in 
the regime heading of the BMQ, which may indicate 
that patients who do not believe in the seriousness of 
SAH have the lowest adherence percentages in this 
heading.
This study observed that when the medication 
was provided in full to the patient, there was a higher 
percentage of treatment adherence. This finding may be 
related to the low socioeconomic status of the studied 
population, who has difficulty meeting the treatment 
costs. One of the factors reported by patients as the 
reason for stopping their treatment is the high cost of 
medication associated with the lack of income to buy 
it, followed by forgetting to use it(9). In contrast, one 
international study showed that the level of adherence 
to medication is higher when medical expenses are 
lower(19). Stimulating adherence to proposed treatment 
is necessary as is raising awareness surrounding the 
costs of non-adherence to treatment and to its impact 
on the health system.
Patients with no dyslipidemia have a higher 
percentage of low adherence to treatment, while 
those with dyslipidemia have a higher percentage 
of moderate adherence (p=0.0322). The association 
between unbalanced nutrition, excessive consumption 
of sodium, carbohydrates and alcohol, physical 
inactivity and smoking are risk factors for the 
appearance of SAH and dyslipidemia; this set of 
factors that are related to the health of the individual 
contribute to this finding(1,20).
Individuals who work from home, those who are 
retired/unemployed (p = 0.0379) and inactive, in 
regards to undertaking physical activities (p=0.0387), 
showed a higher percentage of belief barriers in relation 
to their drug treatment. This finding is similar to that 
made by other studies, in which there was an observed 
low adherence to medication treatment that are related 
to life habits, living with the restrictions the illness 
causes, financial situation and the availability of access 
to health services(17).
Among men and women with a low educational level, 
SAH is more common with increasing age, with it being 
higher for men up to the age of 50 years, which is twice 
as prevalent among non-whites with a predominance of 
black women as it is for white individuals(1,21).
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Conclusion
Most of the hypertensive patients admitted to the 
emergency service were female, with low income and 
low education. These individuals showed that they had 
a moderate understanding of the disease and managed 
moderate treatment adherence, with the main barrier 
to this adherence being forgetfulness in terms of using 
their medication. When the medication was fully supplied 
without charge, the patients showed a higher percentage 
of treatment adherence. There was high correlation 
between the number of drugs used and the recall barrier, 
which suggests that monotherapy is an option that can 
facilitate treatment adherence and, in cases where this is 
not possible, it is necessary that the health team jointly 
look into other strategies with the patient so as to reduce 
how often the patients forget to take their medication.
There is no consensus in the literature regarding the 
best method to evaluate adherence to drug treatment. 
Direct methods, such as taking blood samples are 
costly and difficult to execute; indirect methods, such 
as questionnaires, can be considered and their results 
compared with studies that used other strategies. There 
is no method that is considered excellent, with the use 
of combined approaches often being required.
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